Human TP53(Tumor Protein p53) ELISA Kit
中文名称：人肿瘤蛋白p53(TP53)酶联免疫吸附测定试剂盒
Price:
- 反应性： Human
- 检测范围： 78.13-5000 pg/mL
- 灵敏度： 46.88 pg/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人TP53抗体包被于酶标板上，实验时样品（或标准品）中的人TP53会与包被抗体结合。后依次加入生物素化的抗人TP53抗体和辣根过氧化物酶标记的亲和素，抗人TP53抗体与结合在包被抗体上的人TP53结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，TP53浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中TP53的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Human |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 78.13-5000 pg/mL |
| 灵敏度 | 46.88 pg/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的人TP53，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 数据处理 |
-
Disposable paper-based screen-printed electrochemical immunoplatform for dual detection of esophageal cancer biomarkers in patients' serum samples
IF: 5.000 -
Insight into the molecular mechanism of anti-breast cancer therapeutic potential of substituted salicylidene-based compounds using cell-based assays and molecular docking studies
IF: 4.200 -
Activable Targeted Protein Degradation Platform Based on Light-triggered Singlet Oxygen
IF: 8.039 -
Micro-RNAs in Response to Active Forms of Vitamin D3 in Human Leukemia and Lymphoma Cells
IF: 6.208 -
Exploring the use of p53 protein expression as an indicator of oesophageal cancer severity from a high incidence rural area of Africa
IF: 1.108 -
Predictive value of tissue p53 protein expression and serum p53 antibodies in oral potentially malignant disorders: Relative to oral squamous cell carcinoma
Journal： Journal of Taibah University Medical Sciences (2021)PMID：35722241Reactivity：HumanSample Type：serum -
Suitability of MDA, 8-OHdG and wild-type p53 as genotoxic biomarkers in metal (Co, Ni and Cr) exposed dental technicians: a cross-sectional study
IF: 1.911 -
Potential effects of metformin in DNA BER system based on oxidative status in type 2 diabetes
IF: 3.188 -
Role of metformin on base excision repair pathway in p53 wild-type H2009 and HepG2 cancer cells
IF: 1.802Journal： HUMAN & EXPERIMENTAL TOXICOLOGY (2017)PMID：29185360Reactivity：HumanSample Type：Cell lysate
实验操作视频
